The position demands deep expertise in regulatory requirements including 21 CFR Part 820, 21 CFR Part 803, ISO 13485, ISO 14971, and EU MDR, combined with strong data analytics capabilities to identify trends, detect emerging signals, and support data-driven quality and regulatory decisions. The organization's portfolio spans cardiovascular care, diabetes management, diagnostic testing, nutrition, and neuromodulation including groundbreaking continuous glucose monitoring technology, rapid diagnostic tests, minimally invasive cardiac devices, and nutritional solutions for patients across all life stages.